Mitochondrial disease and our treatment strategies. Primary mitochondrial diseases are rare and often serious conditions with few or no treatment options. Abliva (former NeuroVive), a Swedish pharmaceutical company, focuses on the development of novel treatments for these patients. Find out more at www.abliva.com
source
Abliva – What is mitochondrial disease?
